Share this post on:

Product Name: Pacritinib (SB1518) new featured
Description: Pacritinib, also known as SB1518, is a n orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 act
CAS NO: 1158279-20-9 Product: HLCL-61 (hydrochloride)
Synonym: SB1518; SB 1518; SB-1518; Pacritinib.
IUPAC Chemical Name: 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
In ChiKey: Interleukin Related inhibitors
SMILE Code: C1(C2=NC(NC3=CC=C(OCCN4CCCC4)C(COC/C=C/COC5)=C3)=NC=C2)=CC5=CC=C1
Appearance: Solid powder
Purity: 0.98
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Medchemexpress
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: 5 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22138891
Chemical Formulaļ¼šC28H32N4O3
ExactMass: 472.24744
Molecular Weight: 472.57868
Elemental Analysis: C, 71.16; H, 6.83; N, 11.86; O, 10.16

Share this post on:

Author: bet-bromodomain.